NCT00778700View on ClinicalTrials.gov

A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL

Enrollment

199

Participants

Timeline

Start Date

October 28, 2008

Primary Completion Date

June 26, 2009

Study Completion Date

June 26, 2009

Conditions

Psoriasis

Interventions

OTHER

Placebo Cream

Cream with no active drug

DRUG

Ruxolitinib Phosphate

Ruxolitinib phosphate cream

Trial Locations (28)

Unknown

Hot Springs

Los Angeles

San Diego

Santa Monica

Vallejo

New Haven

Miami

Ormond Beach

Naperville

Wheaton

Evansville

South Bend

Boston

Clinton Township

Fridley

St Louis

Albuquerque

Rochester

Norman

Simpsonville

Austin

College Station

Dallas

Houston

Salt Lake City

Norfolk

Walla Walla

Madison

Sponsors

Lead Sponsor

Incyte Corporation

All Listed Sponsors

lead

Incyte Corporation

INDUSTRY

NCT00778700 - A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis | Biotech Hunter | Biotech Hunter